Cargando…
Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis
A graded challenge with adalimumab could be safe in case of a delayed allergic reaction to golimumab, after a detailed allergological evaluation and the exclusion of allergic sensitization using skin tests.
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037302/ https://www.ncbi.nlm.nih.gov/pubmed/36968346 http://dx.doi.org/10.1002/ccr3.7067 |
| Sumario: | A graded challenge with adalimumab could be safe in case of a delayed allergic reaction to golimumab, after a detailed allergological evaluation and the exclusion of allergic sensitization using skin tests. |
|---|